Clifford Chance advised healthcare group Fresenius and its Spanish subsidiary QuironSalud on the deal.Fresenius sells its 70% stake in IDCQ CRP, a co-holding entity of the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
